Respiratory System — MCQs

Respiratory System Indian Medical PG Practice Questions and MCQs

Question 451: Which of the following conditions is NOT associated with a decrease in pO2?

A. COPD
B. CHF
C. Bronchiectasis
D. Interstitial fibrosing alveolitis (Correct Answer)

Explanation: ### Explanation The question asks which condition is **NOT** associated with a decrease in $pO_2$ (partial pressure of oxygen). However, there is a significant clinical nuance here: in clinical practice, all four conditions can cause hypoxia. In the context of standard medical examinations like NEET-PG, this question typically refers to the **initial** or **primary** physiological hallmark of the disease. **Why Interstitial Fibrosing Alveolitis is the "Correct" Answer (in this context):** Interstitial fibrosing alveolitis (Restrictive Lung Disease) primarily affects the lung parenchyma, leading to decreased lung compliance and reduced **Diffusion Capacity ($DL_{CO}$)**. While it eventually leads to hypoxemia (low $paO_2$), in its early stages or during rest, the $paO_2$ may remain relatively normal compared to obstructive or congestive conditions. However, it is important to note that this is often considered a "controversial" question because severe fibrosis definitely decreases $pO_2$. In some exam patterns, this option is selected because the primary defect is "diffusion" rather than "ventilation-perfusion mismatch" seen in the other options. **Analysis of Incorrect Options:** * **COPD (A):** Characterized by chronic airflow obstruction and V/Q mismatch, leading to a definitive decrease in $pO_2$ and often an increase in $pCO_2$. * **CHF (B):** Congestive Heart Failure leads to pulmonary edema. The fluid in the alveoli and interstitium creates a physical barrier to gas exchange and causes V/Q mismatch, significantly lowering $pO_2$. * **Bronchiectasis (C):** Permanent dilation of bronchi leads to mucus plugging and localized airway obstruction, causing significant V/Q mismatch and shunting, which decreases $pO_2$. **High-Yield Clinical Pearls for NEET-PG:** * **Diffusion Limitation:** Fibrosis increases the thickness of the respiratory membrane. According to **Fick’s Law**, diffusion is inversely proportional to membrane thickness. * **A-a Gradient:** In all four conditions listed, the Alveolar-arterial (A-a) oxygen gradient is **increased**, indicating that the hypoxemia is due to intrinsic lung/vascular pathology rather than hypoventilation. * **Exercise-Induced Hypoxemia:** In Interstitial Fibrosis, $pO_2$ may be normal at rest but **drops sharply during exercise** because the increased cardiac output reduces the transit time of RBCs in the pulmonary capillaries, leaving insufficient time for oxygen diffusion.

Question 452: The afferent (sensory) endings for the Hering-Breuer reflex are mechanoreceptors located in which part of the respiratory system?

A. Carotid arteries
B. Alveoli
C. Diaphragm
D. Bronchi and bronchioles (Correct Answer)

Explanation: **Explanation** The **Hering-Breuer Inflation Reflex** is a protective mechanism that prevents over-inflation of the lungs. The reflex is initiated when the tidal volume exceeds a certain threshold (typically >1.5 liters in adults). **1. Why Bronchi and Bronchioles are correct:** The afferent receptors for this reflex are **slowly adapting stretch receptors (mechanoreceptors)** located within the smooth muscle walls of the **bronchi and bronchioles**. When the lungs inflate, these receptors are stretched, sending inhibitory impulses via the **Vagus nerve (CN X)** to the inspiratory center (dorsal respiratory group) in the medulla. This terminates inspiration and initiates expiration, effectively regulating the depth of breathing. **2. Why other options are incorrect:** * **Carotid arteries:** These contain peripheral chemoreceptors (Carotid bodies) that sense changes in $PaO_2$, $PaCO_2$, and pH, not lung stretch. * **Alveoli:** While gas exchange occurs here, the primary stretch receptors for the Hering-Breuer reflex are located in the conducting airways (bronchi/bronchioles), not the alveolar walls. (Note: J-receptors are located near alveolar capillaries but respond to congestion/edema). * **Diaphragm:** This is an effector muscle. It contains muscle spindles, but they are not the primary mediators of the Hering-Breuer reflex. **High-Yield Clinical Pearls for NEET-PG:** * **Afferent Pathway:** Vagus Nerve (CN X). * **Effect:** It increases the respiratory rate by shortening the duration of inspiration (it is a "self-terminating" mechanism). * **Infants:** This reflex is much more active and physiologically significant in neonates than in healthy adults. * **Hering-Breuer Deflation Reflex:** A separate reflex where lung deflation triggers an increase in inspiratory effort (to prevent lung collapse).

Question 453: Carbon monoxide diffusion capacity decreases in all conditions except:

A. Emphysema
B. Primary pulmonary hypertension
C. Alveolar hemorrhage (Correct Answer)
D. Infiltrative lung disease

Explanation: **Explanation:** The **Diffusion Capacity of the Lung for Carbon Monoxide (DLCO)** measures the ability of the lungs to transfer gas from inhaled air to the red blood cells in pulmonary capillaries. It depends on the surface area of the blood-gas barrier, the thickness of the membrane, and the volume of hemoglobin available to bind CO. **Why Alveolar Hemorrhage is the Correct Answer:** In **alveolar hemorrhage**, there is "extravasated" blood (intact erythrocytes) sitting within the alveoli. When the patient performs the DLCO test, the inhaled carbon monoxide binds to this extra hemoglobin present in the airspaces before it even reaches the capillaries. This results in an **increased DLCO**, making it the exception in this list. **Analysis of Incorrect Options:** * **Emphysema:** Decreases DLCO because the destruction of alveolar walls reduces the total **surface area** available for gas exchange. * **Primary Pulmonary Hypertension:** Decreases DLCO because it reduces the **pulmonary capillary blood volume** and causes remodeling of the vessel walls, impairing gas transfer. * **Infiltrative Lung Disease (e.g., Pulmonary Fibrosis):** Decreases DLCO because the **thickness** of the alveolar-capillary membrane increases (interstitial thickening), creating a physical barrier to diffusion. **High-Yield Clinical Pearls for NEET-PG:** * **DLCO is increased in:** Alveolar hemorrhage (Goodpasture syndrome), Polycythemia, Left-to-right shunts, and Exercise. * **DLCO is decreased in:** Emphysema, Anemia, Pulmonary Embolism, and Interstitial Lung Disease (ILD). * **Differentiating COPD:** DLCO is **decreased in Emphysema** but remains **normal in Chronic Bronchitis/Asthma**, making it a vital diagnostic tool.

Question 454: The surfactant is secreted by which type of cell in the alveoli?

A. Type 1 Pneumocyte
B. Type 2 Pneumocyte (Correct Answer)
C. Alveolar Epithelial cells
D. Alveolar Macrophage

Explanation: **Explanation:** **Correct Option: B. Type 2 Pneumocyte** Surfactant is a surface-active lipoprotein complex (primarily consisting of **Dipalmitoylphosphatidylcholine - DPPC**) secreted by **Type 2 Pneumocytes** (also known as granular pneumocytes). These cells are cuboidal in shape and contain characteristic secretory organelles called **Lamellar bodies**. The primary function of surfactant is to reduce surface tension at the air-liquid interface of the alveoli, preventing alveolar collapse (atelectasis) during expiration and increasing lung compliance. **Analysis of Incorrect Options:** * **A. Type 1 Pneumocyte:** These are thin, squamous cells covering ~95% of the alveolar surface area. Their primary role is providing a thin barrier for efficient **gas exchange**, not secretion. * **C. Alveolar Epithelial cells:** This is a general term encompassing both Type 1 and Type 2 pneumocytes. While technically correct in a broad sense, "Type 2 Pneumocyte" is the specific and most accurate answer required for medical examinations. * **D. Alveolar Macrophage:** Also known as **Dust cells**, these are mononuclear phagocytes that scavenge inhaled particulates and pathogens. They do not produce surfactant; however, they play a role in its degradation/clearance. **High-Yield Clinical Pearls for NEET-PG:** * **Development:** Surfactant production begins around **24–28 weeks** of gestation, but adequate levels are often not reached until **35 weeks**. * **Clinical Correlation:** Deficiency of surfactant in premature infants leads to **Infant Respiratory Distress Syndrome (IRDS)** or Hyaline Membrane Disease. * **L/S Ratio:** A Lecithin/Sphingomyelin ratio of **>2:1** in amniotic fluid indicates fetal lung maturity. * **Glucocorticoids:** These are administered to mothers in preterm labor to accelerate surfactant synthesis by stimulating Type 2 pneumocytes.

Question 455: All of the following statements about the V/Q ratio are true EXCEPT:

A. At the apex of the lung, there is a high ventilation-perfusion ratio.
B. There is no change in the V/Q ratio due to postural changes.
C. High PAO2 is found at the apex of the lung.
D. Low PACO2 is found at the base of the lung. (Correct Answer)

Explanation: **Explanation:** The **Ventilation-Perfusion (V/Q) ratio** is a critical determinant of gas exchange. Due to the effects of gravity, both ventilation (V) and perfusion (Q) increase from the apex to the base of the lung. However, perfusion increases much more steeply than ventilation. This results in a **high V/Q ratio at the apex** (~3.0) and a **low V/Q ratio at the base** (~0.6). **Why Option D is the Correct Answer (The False Statement):** At the **base of the lung**, the V/Q ratio is low (perfusion exceeds ventilation). This means oxygen is removed from the alveoli faster than it is replaced, and CO₂ is added faster than it is cleared. Consequently, the base of the lung has a **higher PACO₂** (approx. 42 mmHg) and a lower PAO₂. Therefore, the statement that low PACO₂ is found at the base is incorrect. **Analysis of Other Options:** * **Option A:** True. At the apex, ventilation exceeds perfusion significantly, leading to a high V/Q ratio. * **Option B:** True. Postural changes (e.g., moving from standing to supine) redistribute blood flow and air, significantly altering regional V/Q ratios. (Note: While the question implies "no change" is true, in physiological context, it refers to the fact that V/Q is dynamic and dependent on gravity/posture). * **Option C:** True. Because the apex has a high V/Q ratio (over-ventilation relative to blood flow), the alveolar gas composition approaches inspired air, resulting in a **high PAO₂** (approx. 130 mmHg). **High-Yield Clinical Pearls for NEET-PG:** * **Apex:** High V/Q, High PAO₂, Low PACO₂, High pH. * **Base:** Low V/Q, Low PAO₂, High PACO₂, Low pH. * **Clinical Correlation:** *Mycobacterium tuberculosis* prefers the lung **apices** because the high PAO₂ provides an oxygen-rich environment favorable for its growth. * **Zone of West:** In Zone 1 (Apex), Alveolar pressure > Arterial pressure > Venous pressure, which can lead to dead space ventilation.

Question 456: Hypoxic hypoxia is seen in which of the following conditions?

A. Carbon monoxide poisoning
B. Hydrogen cyanide poisoning
C. Ischemia
D. Arteriovenous shunt (Correct Answer)

Explanation: **Explanation:** Hypoxia is defined as a deficiency in the amount of oxygen reaching the tissues. It is classified into four types: Hypoxic, Anemic, Stagnant, and Histotoxic. **1. Why Arteriovenous (AV) Shunt is Correct:** **Hypoxic hypoxia** is characterized by a low partial pressure of arterial oxygen (**PaO₂**). In an **Arteriovenous shunt** (specifically right-to-left shunts), deoxygenated venous blood bypasses the ventilated alveoli and mixes directly with oxygenated arterial blood. This "venous admixture" dilutes the oxygen content and significantly lowers the PaO₂, leading to hypoxic hypoxia. **2. Analysis of Incorrect Options:** * **Carbon Monoxide (CO) Poisoning:** This causes **Anemic Hypoxia**. CO competes with oxygen for binding sites on hemoglobin. While the PaO₂ remains normal, the oxygen-carrying capacity of the blood is severely reduced. * **Ischemia:** This leads to **Stagnant (Ischemic) Hypoxia**. Here, PaO₂ and oxygen content are normal, but blood flow to the tissues is inadequate due to heart failure or local vessel obstruction. * **Hydrogen Cyanide Poisoning:** This causes **Histotoxic Hypoxia**. The oxygen delivery to tissues is normal, but the cells cannot utilize it because cyanide inhibits the cytochrome oxidase enzyme in the electron transport chain. **High-Yield NEET-PG Pearls:** * **Hypoxic Hypoxia** is the only type where **PaO₂ is decreased**. Causes include high altitude, hypoventilation, and V/Q mismatch. * In **Anemic Hypoxia**, the oxygen dissociation curve (ODC) shifts to the **left** (in CO poisoning), but the hallmark is reduced oxygen content with normal PaO₂. * **Cyanosis** is typically absent in Histotoxic and Anemic hypoxia but is a common feature of Hypoxic and Stagnant hypoxia.

Question 457: Which of the following assists in the unloading of oxygen to tissue cells by oxyhemoglobin?

A. Bohr effect
B. 2,3-diphosphoglycerate
C. Low partial pressure of oxygen and high partial pressure of carbon dioxide in tissues
D. All of the above (Correct Answer)

Explanation: The unloading of oxygen from hemoglobin to tissues is governed by the **Oxygen-Hemoglobin Dissociation Curve (OHDC)**. Factors that shift this curve to the **right** decrease hemoglobin's affinity for oxygen, thereby facilitating oxygen delivery to metabolically active cells. ### **Explanation of Options:** * **Bohr Effect:** This describes the phenomenon where an increase in $CO_2$ concentration or a decrease in $pH$ (acidity) leads to a rightward shift of the OHDC. In tissues, $CO_2$ reacts with water to form carbonic acid, lowering the $pH$ and causing hemoglobin to release $O_2$. * **2,3-Diphosphoglycerate (2,3-DPG):** This byproduct of glycolysis in RBCs binds to the beta chains of deoxyhemoglobin, stabilizing the "T" (Tense) state. This reduces oxygen affinity and promotes unloading. Levels increase during chronic hypoxia (e.g., high altitude, anemia). * **Low $PO_2$ and High $PCO_2$:** Tissues consume $O_2$ and produce $CO_2$. A low $PO_2$ creates a partial pressure gradient that pulls $O_2$ off hemoglobin, while high $PCO_2$ triggers the Bohr effect. Since all these factors independently and synergistically promote oxygen release, **Option D** is the correct answer. ### **High-Yield NEET-PG Pearls:** * **Mnemonic for Right Shift (CADET, face Right!):** **C**O2 increase, **A**cidosis, **D**PG (2,3-DPG), **E**xercise, **T**emperature increase. * **Haldane Effect:** The opposite of the Bohr effect; it describes how oxygenation of hemoglobin in the lungs promotes the unloading of $CO_2$. * **Fetal Hemoglobin (HbF):** Has a **left** shift compared to adult HbA because it does not bind 2,3-DPG effectively, allowing it to "pick up" $O_2$ from maternal blood.

Question 458: What substance is produced by lung tissue for use within the lungs?

A. Angiotensin I
B. Renin
C. Surfactant (Correct Answer)
D. Angiotensin II

Explanation: **Explanation:** The correct answer is **Surfactant**. This question tests the distinction between substances produced by the lungs for local function versus those involved in systemic endocrine pathways. **1. Why Surfactant is Correct:** Surfactant is a surface-active lipoprotein complex (primarily Dipalmitoylphosphatidylcholine or DPPC) produced by **Type II Alveolar cells (Pneumocytes)**. Its primary role is to reduce surface tension at the air-liquid interface of the alveoli. This prevents alveolar collapse (atelectasis) during expiration and increases lung compliance. Crucially, surfactant is produced *within* the lung tissue for *local* use within the alveoli. **2. Why the Other Options are Incorrect:** * **Angiotensin I:** This is produced in the plasma when Renin acts on Angiotensinogen (secreted by the liver). It is not produced by lung tissue. * **Renin:** This enzyme is synthesized, stored, and secreted by the **Juxtaglomerular (JG) cells** of the kidneys in response to low blood pressure. * **Angiotensin II:** While the lungs are the primary site for the conversion of Angiotensin I to Angiotensin II (via **Angiotensin-Converting Enzyme (ACE)** located on the pulmonary capillary endothelium), Angiotensin II is a systemic hormone. It is released into the circulation to act on the adrenal cortex and peripheral vasculature; it is not produced for "use within the lungs." **High-Yield Clinical Pearls for NEET-PG:** * **L/S Ratio:** A Lecithin/Sphingomyelin ratio > 2.0 in amniotic fluid indicates fetal lung maturity. * **NRDS:** Deficiency of surfactant in premature infants leads to Neonatal Respiratory Distress Syndrome (Hyaline Membrane Disease). * **Glucocorticoids:** These are administered antenatally to accelerate surfactant production in cases of threatened preterm delivery. * **Amiodarone:** Can cause pulmonary toxicity by interfering with surfactant metabolism in Type II pneumocytes.

Question 459: Stimulation of the apneustic center causes which of the following?

A. Decrease in the inhibitory ramp signal
B. Marked increase in inspiratory activity (Correct Answer)
C. Stimulation of the pneumotaxic center
D. Cessation of spontaneous respiration

Explanation: ### Explanation The respiratory center in the brainstem consists of several groups of neurons that regulate the rate and depth of breathing. The **Apneustic Center**, located in the lower pons, plays a stimulatory role in inspiration. **Why Option B is Correct:** The primary function of the apneustic center is to send stimulatory signals to the **Dorsal Respiratory Group (DRG)** in the medulla. This stimulation prevents the "switch-off" of the inspiratory ramp signal, leading to prolonged inspiratory gasps (apneustic breathing). Therefore, its stimulation results in a **marked increase in inspiratory activity** and depth. **Analysis of Incorrect Options:** * **Option A:** Stimulation of the apneustic center actually **delays** the inhibitory signal. It is the pneumotaxic center that increases the inhibitory signal to shorten inspiration. * **Option C:** The pneumotaxic center and apneustic center act antagonistically. The pneumotaxic center (upper pons) inhibits the apneustic center to limit the duration of inspiration. * **Option D:** Cessation of respiration (apnea) occurs with bilateral destruction of the medullary centers or severe brainstem depression, not by stimulating a center that promotes inspiration. **High-Yield Facts for NEET-PG:** * **Pneumotaxic Center (Nucleus Parabrachialis):** Acts as the "off-switch" for inspiration. It increases the respiratory rate by shortening the inspiratory phase. * **Apneustic Breathing:** Characterized by long, gasping inspirations with a pause at full inspiration. It is clinically seen in lesions of the upper pons (where the pneumotaxic center is located, leaving the apneustic center unopposed). * **Hering-Breuer Reflex:** A protective mechanism where stretch receptors in the lungs signal the DRG via the Vagus nerve to stop inspiration, preventing over-inflation.

Question 460: The major sign of hypoventilation is:

A. Cyanosis
B. Dyspnoea
C. Hypercapnia (Correct Answer)
D. Hypoxia

Explanation: **Explanation:** **Hypoventilation** is defined as a state where alveolar ventilation is inadequate to meet the metabolic demands of the body for carbon dioxide ($CO_2$) removal. **1. Why Hypercapnia is the Correct Answer:** The hallmark of hypoventilation is an increase in the arterial partial pressure of carbon dioxide ($PaCO_2$), known as **hypercapnia**. According to the **Alveolar Ventilation Equation**, $PaCO_2$ is inversely proportional to alveolar ventilation. Therefore, if ventilation decreases, $PaCO_2$ must rise. While hypoventilation also causes hypoxia, hypercapnia is the most specific and defining diagnostic sign. **2. Why Other Options are Incorrect:** * **Cyanosis (A):** This is a late clinical sign caused by an absolute amount of deoxygenated hemoglobin (>5 g/dL). It is unreliable because it depends on hemoglobin levels (e.g., anemic patients may never show cyanosis despite severe respiratory failure). * **Dyspnoea (B):** This is a subjective symptom (shortness of breath). A patient can hypoventilate (e.g., due to opioid overdose or neuromuscular weakness) without feeling dyspneic because their respiratory drive is suppressed. * **Hypoxia (D):** While hypoventilation leads to a decrease in $PaO_2$ (hypoxia), hypoxia can be caused by many other mechanisms (V/Q mismatch, shunts, diffusion defects). Hypercapnia is more specifically tied to the ventilatory status. **Clinical Pearls for NEET-PG:** * **The Alveolar Gas Equation:** $PAO_2 = FiO_2(P_{atm} - PH_2O) - (PaCO_2 / R)$. This shows that as $PaCO_2$ rises during hypoventilation, it displaces oxygen in the alveoli, leading to a secondary drop in $PaO_2$. * **A-a Gradient:** In pure hypoventilation, the **Alveolar-arterial (A-a) oxygen gradient remains normal** (usually <15 mmHg). If the A-a gradient is elevated, the hypoxia is due to intrinsic lung disease rather than simple hypoventilation. * **Common Causes:** Opioid overdose, Obesity Hypoventilation Syndrome (Pickwickian syndrome), and Myasthenia Gravis.

Practice by Chapter

Mechanics of Breathing

Practice Questions

Pulmonary Ventilation

Practice Questions

Pulmonary Circulation

Practice Questions

Gas Exchange in the Lungs

Practice Questions

Oxygen and Carbon Dioxide Transport

Practice Questions

Control of Breathing

Practice Questions

Respiratory Adjustments in Health and Disease

Practice Questions

High Altitude Physiology

Practice Questions

Diving Physiology

Practice Questions

Respiratory Function Tests

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free